NASDAQ, ATRC - Atricure Inc
We are a medical device company and a leader in developing, manufacturing and
selling innovative cardiac surgical ablation systems designed to create precise
lesions, or scars, in cardiac, or heart, tissue. Medical journals have described
the adoption by leading cardiothoracic surgeons of our Isolator ? bipolar
ablation clamp system as a treatment alternative during open-heart surgical
procedures to create lesions in cardiac tissue to block the abnormal electrical
impulses that cause atrial fibrillation, or AF, a rapid, irregular quivering of
the upper chambers of the heart. Additionally, leading cardiothoracic surgeons,
treatment guidelines as published by the Heart Rhythm Society and publications
in medical journals have described our Isolator ? system as a standard treatment
alternative for AF patients who may be candidates for sole-therapy minimally
invasive surgical procedures. ...
Read SEC Filing on NASDAQ.com »